Abstract:OBJECTIVE: To investigate the expression of serine protease Omi/HtrA2 in kidneys of postasphyxial neonatal rats, and to study the effects of Ucf-101 on apoptosis and the expression of Omi/HtrA2 in these rats. METHODS: Seventy-two neonatal Wistar rats of 7-10 days old were randomly divided into 3 groups: control, postasphyxial model, Ucf-101-treated postasphyxial.The postasphyxial model was established by normobaric asphyxia.Expression of Omi/HtrA2 was determined with streptavidin-peroxidase immunohistochemistry 2, 24 and 48 hrs after asphyxia. Terminal deoxynuleotidyl-mediated nick end labeling (TUNEL) was used to ascertain the apoptosis of renal cells. RESULTS: Compared with the control group, Omi/HtrA2 expression in renal cells began to increase 2 hrs after asphyxia and peaked at 24 hrs. The expression of Omi/HtrA2 in the Ucf-101-treated postasphyxial group was significantly lower than that in the postasphyxial model group (P<0.01). TUNEL-positive cells began to increase 2 hrs after asphyxia and peaked at 24 hrs in the postasphyxial model group when compared with the control group. The number of TUNEL-positive cells in the Ucf-101-treated postasphyxial group was significantly lower than that in the postasphyxial model group at all time points (P<0.01). CONCLUSIONS: The expression of Omi/HtrA2 in kidneys is increased in postasphyxial neonatal rats. The increased Omi/HtrA2 expression may play an important role in the development of postasphyxial renal injury. Treatment with Ucf-101 can reduce the expression of Omi/HtrA2 in kidneys of postasphyxial neonatal rats and thus reduce renal tububar epithelial cell apoptosis.[Chin J Contemp Pediatr, 2010, 12 (8):658-661]
HUA Bing,DONG Wen-Bin,LI Qing-Ping et al. Effects of Ucf-101 on expression of Omi/HtrA2 in kidneys of postasphyxial neonatal rats[J]. CJCP, 2010, 12(08): 658-661.
[2]Wang CY, Lin YS, Su WC, Chen CL, Lin CF. Glycogen synthase kinase-3 and Omi/HtrA2 induce annexin A2 cleavage followed by cell cycle inhibition and apoptosis[J]. Mol Biol Cell, 2009, 20(19):4153-4161.
[5]Su D, Su Z, Wang J, Yang S, Ma J. UCF-101, a novel Omi/HtrA2 inhibitor, protects against cerebral ischemia/reperfusion injury in rats[J]. Anat Rec (Hoboken), 2009, 292(6):854-861.
[6]Althaus J, Siegelin MD, Dehghani F, Cilenti L, Zervos AS, Rami A. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion[J]. Neurochem Int, 2007, 50(1):172-180.
[8]Okazaki K, Kondo M, Kato M, Kakinuma R, Nishida A, Noda M, et al.Elevation of cytokine concentrations in asphyxiated neonates [J].Biol Neonate, 2006, 89(3):183-189.
[9]Chang L,Kamata H,Solinas G,Luo JL, Maeda S, Venuprasad K, et al .The E3 ubiquitin ligase itch couples JNK activation to TNF-α-induced cell death by inducing c-FLIP(L)turnover[J].Cell, 2006, 124(3):601-613.
[10]Belizario JE,Alves J,Occhiucci JS,Garay-Malpartida M, Sesso A. A mechanistic view of mitochondrial death decision pores[J].Braz J Med Biol Res, 2007, 40(8):1011-l024.
[11]Kin H,Wang NP,Halkos ME, Kerendi F, Guyton RA, Zhao ZQ. Neutrophil depletion reduces myocardial apoptosis and attenuates NF-κB activation /TNF-α release after ischemia and reperfusion [J].J Surg Res, 2006, 135(1):170-178.
[12]Li Q, Hueckstaedt LK, Ren J.UCF101 Ameliorates streptozotocin-induced cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase[J]. Exp Physiol, 2009, 94(9):984-994.
[13]Liu HR, Gao E, Hu A, Tao L, Qu Y, Most P, et al. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion[J]. Circulation, 2005, 111(1):90-96.
[14]Bhuiyan MS, Fukunaga K. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury[J]. Cardiovasc Ther, 2008, 26(3):224-232.